Scott Wilkinson - Inogen Insider

INGN -- USA Stock  

USD 213.16  2.84  1.35%

Pres and COO
Mr. Scott Wilkinson is President, Chief Executive Officer, Director of the Company. He has served as our Chief Executive Officer and President since March 1, 2017, and a Member of our Board since January 1, 2017. Previously, he served as our President and Chief Operating Officer from January 1, 2016 until March 1, 2017, and our Executive Vice President, Sales and Marketing from 2008 through December 31, 2015, and in this role he oversaw Inogens global operations in sales, marketing, customer service, product management, medical billing, and clinical services. Prior to that, he served as our Director of Product Management from 2005 to 2006 and Vice President, Product Management from 2006 to 2008. From 2000 to 2005, Mr. Wilkinson worked for Invacare Corporationrationration, a designer and manufacturer of oxygen products, as a Group Product Manager and helped launch their 100 million oxygen product line segment. From 1999 to 2000, Mr. Wilkinson served as a Product Line Director with Johnson Johnson, a healthcare company. From 1988 to 1999, Mr. Wilkinson worked as a Research Scientist, Product Manager, and Project Leader at Kimberly Clark, a consumer products company
Age: 52  COO Since 2017  MBA    
805-562-0500  http://www.inogen.com
Wilkinson received a Bachelor?s degree in Chemical Engineering from the University of Akron and an MBA from University of Wisconsin, Oshkosh. The Board believes that Mr. Wilkinson?s considerable knowledge and understanding of our business together with his extensive industry experience qualifies him to serve as a director of Inogen.

Scott Wilkinson Latest Insider Activity

Scott Wilkinson over six months ago via Macroaxis 
Sale by Scott Wilkinson of 8043 shares of Inogen

Management Efficiency

The company has return on total asset (ROA) of 7.53 % which means that it generated profit of $7.53 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 11.76 % meaning that it created $11.76 on every $100 dollars invested by stockholders.

Similar Executives

Found 1 records

COO Since

Mark WallaceEscalon Medical Corp
2017

Entity Summary

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California. Inogen operates under Medical Devices classification in USA and traded on BATS Exchange. It employs 770 people.Inogen (INGN) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 770 people. Inogen is listed under Medical Equipment category by Fama And French industry classification.

Inogen Leadership Team

Scott Beardsley, Director
Byron Myers, Founder, MBA
Raymond Huggenberger, CEO
Heath Lukatch, Chairman, Ph.D
Heather Rider, Director, MBA
Loren McFarland, Director, CFA
Scott Greer, Director, MBA
Benjamin AndersonRay, Director, MBA
Matthew Scribner, President, MBA
Alison Bauerlein, Founder
Scott Wilkinson, COO, MBA
Brenton Taylor, Founder

Stock Performance Indicators

Did you try this?

Run Portfolio Optimization Now
   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Portfolio Optimization

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.